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Abstract
Background: It has been suggested that the higher prevalence of cataract in women is caused by a
withdrawal effect of oestrogen at menopause. In vitro studies have demonstrated protection of serum
oestradiol (E2) against oxidative stress through upregulation of antioxidant enzymes, including superoxide
dismutase (SOD). The purpose of the present study was to investigate E2 levels and SOD erythrocyte activity
in patients with age-related cataract.
Methods: The studied subjects consisted of 103 patients with age-related cataract and 22 controls. Cataracts
were classified as nuclear, cortical, or posterior subcapsular. Blood samples were collected and data on
smoking, hormonal use, diabetes and age at menarche/menopause was obtained for all individuals. Serum
oestradiol analyses were performed with radioimmunoassay (RIA) and SOD activity was measured in
erythrocyte lysates.
Results: A negative correlation between age and E2 concentration was seen in a linear regression analysis.
No correlation was seen between SOD activity and age or gender and no correlation between E2 levels and
SOD activity was found using multiple linear regression. The mean level of E2 for all male subjects was 50.1
± 16.3 pmol/L, significantly higher compared to 13.8 ± 11.8 pmol/L for postmenopausal women.
Conclusion: The present study does not support a role for E2-induced effects on SOD in cataract formation.
The findings of higher E2 levels in men than in postmenopausal women may suggest that decreased
oestrogen at menopause is partially responsible for the gender-related difference in cataract prevalence.
However, the latter can only be verified through prospective randomized trials using hormonal replacement
therapy.
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Background
Cataract is the most common cause of blindness in the
world and as lifespan is getting longer, an increased
number of people requiring cataract surgery can be an-
ticipated. Several studies report higher prevalence of lens
opacities in women as compared to men of the same age
[1–3]. It has been proposed that with the dramatic
reduction in oestradiol levels in women entering meno-
pause, the potentially protective effects of oestrogen are
withdrawn, resulting in increased risk of cataract in
women. Studies have shown that earlier menarche and
later menopause, causing an extended period of repro-
ductive years, are associated with lower risk of cataract
and that the use of exogenous oestrogens, i.e. hormonal
replacement therapy (HRT), is associated with decreased
risk of cataract. It has therefore been suggested that
oestrogen may protect against cataract. The Blue Moun-
tain Eye study reported that current HRT users had
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lower risk of developing cortical cataract and this was
also confirmed in the follow-up study [4]. Current and
longer use of HRT showed lower incidence of nuclear
lens opacities in both the Beaver Dam Eye Study and the
Framingham Eye Study cohort [5, 6].
Oxidative stress is a key factor in cataract formation.
The major oestrogen, oestradiol (E2), has been ascribed
antioxidant properties and several studies have shown
oestrogen-mediated protection against oxidative stress
through upregulation of antioxidant enzymes including
superoxide dismutase (SOD) [7–9]. In addition, lens epi-
thelial cells have also shown increased SOD activity after
exposure to E2 [10]. Therefore, the purpose of the
present study was to investigate possible correlations be-
tween SOD activity and E2 levels in patients with age-
related cataract and controls.
Methods
Patients
Patients with age-related cataract and controls were re-
cruited from the Eye Clinic at Sahlgrenska University
Hospital/Mölndal, after informed consent. The Regional
Research Ethics Committee in Gothenburg approved the
study and the tenets of the Declaration of Helsinki were
followed. The studied subjects consisted of 103 patients
with age-related cataract and 22 controls. Cataracts were
classified as nuclear, cortical, or posterior subcapsular
using biomicroscopy performed by four different sur-
geons. Patients with secondary cataracts, such as
steroid-induced cataract, were excluded. Controls were
either spouses or relatives to glaucoma patients, had
glaucoma themselves or were recruited from the emer-
gency ophthalmic clinic, with diagnoses such as vitreous
detachment or blepharitis. Exclusion criteria for controls
were previous cataract surgery, age <60 years or current
lens opacities. The latter was evaluated by slit lamp
biomicroscopy by one ophthalmologist only. Data on
smoking (current/former smoking habits), hormones
(current/former use of contraceptives and/or hormone
replacement therapy), diabetes and age at menarche/
menopause was obtained for all individuals and age was
reported at the time of sample collection (Table 1).
Blood sampling
Venous blood samples were drawn from patients and
controls and collected using tubes with anticoagulant
(EDTA) for whole blood samples and tubes with clot ac-
tivator and gel separator for serum samples (VACU-
ETTE, Greiner Bio-One, Kremsmünster, Austria). The
whole blood samples were handled the same day and
erythrocytes were collected after centrifugation at 800 ×
g for 10 min at 4 °C. The erythrocytes were then lysed in
four times its volume of ice-cold distilled water after
which the samples were centrifuged at 10.000 × g for
15 min at 4 °C and erythrocyte lysate was collected. The
serum sample tubes were centrifuged at 1800 × g for
10 min after coagulation, within 3 h after sampling. Both
aliquots of serum and erythrocyte lysate were stored at
−80 °C until assayed.
Oestradiol levels
Serum oestradiol analyses were performed with radio-
immunoassay (Spectria Estradiol RIA, Orion Diagnostica,
Table 1 Demographics of studied patients with age-related
cataract and controls
Parameter Cataract Controls p-value
Age (years) n = 103 n = 22
71 ± 10.9 70 ± 3.4 0.35
Sex n = 103 n = 22
Female 61 (59.2) 16 (72.7)
0.24
Male 42 (40.8) 6 (27.3)
Type of lens opacitya n = 100
Nuclear 93 (93.0) - -
Cortical 42 (42.0) -
Posterior subcapsular 23 (23.0) -
Mixed cataract n = 102
Yes 51 (50.0) - -
No 51 (50.0) -
Diabetes n = 103 n = 22
Yes 20 (19.4) - 0.02
No 83 (80.6) 22 (100)
Smoking n = 103 n = 22
Current smoker 19 (18.4) 1 (4.5) 0.11
Ever smokerb 69 (67.0) 12 (54.5) 0.27
Hormonal status n = 102 n = 18
Currently on hormones 9 (8.8) 3 (16.7) 0.31
Ever on hormonesb 43 (42.2) 11 (61.1) 0.14
Menarche / Menopause
Age at menarche n = 57 n = 12
13 ± 1.3 13 ± 1.4 0.64
Age at menopause n = 50 n = 13
49 ± 6.8 50 ± 3.6 0.49
Years in menopausec n = 50 n = 13
24 ± 11.7 20 ± 5.8 0.16
Reproductive years n = 48 n = 12
35 ± 6.9 38 ± 3.2 0.27
Data presented as absolute numbers (%) or mean ± SD. P-values were calculated
with Pearson’s chi-square test for categorical parameters and Student’s t-test for
continuous parameters
a Both eyes included. Many individuals had more than one subtype, i.e.
mixed cataract
b Includes former and current users
c Years in menopause prior to sampling
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Espoo, Finland) with an extraction step prior to quantifi-
cation, yielding a sensitivity of 4 pmol/L, previously de-
scribed by Ankarberg-Lindberg et al. [11]. The assay
measures total oestradiol (17β-oestradiol) serum concen-
trations i.e. both free E2 and E2 previously bound to sex
hormone-binding globulin (SHBG) or albumin.
Total superoxide dismutase activity
SOD activity was measured in erythrocyte lysate samples
using the Superoxide Dismutase Assay kit, according to
the manufacturer’s protocol (Cayman Chemical Com-
pany, Ann Arbor, MI, USA). Absorbance was measured
at 440 nm on the microplate reader Infinite M200 PRO
(Tecan group Ltd., Männedorf, Switzerland) using 96-
well microplates (Greiner Bio-One, Kremsmünster,
Austria). The SOD assay uses tetrazolium salt to detect
superoxide radicals generated by xanthine oxidase and
hypoxanthine. One unit (U) of SOD is defined as the
amount of enzyme needed to execute 50% dismutation
of the superoxide radical. The assay measures total SOD
activity per millilitre erythrocyte lysate (U/ml).
Statistical analysis
Demographic differences between cataract patients and
control subjects were analysed using Student’s t-test for
continuous parameters and Pearson’s chi-square test for
categorical parameters (Table 1). Multiple linear regres-
sion was used to analyse potential predictors of the
dependent variables; E2 levels and SOD activity. In the
initial multivariate analysis, cataract type, smoking, dia-
betes, age at menarche/menopause and hormonal status
were included, but since they showed no statistical sig-
nificance they were excluded in the final model. Statis-
tical analyses were performed using IBM SPSS Statistics
21.0 (IBM Corp., Armonk, NY, USA) and p-values ≤0.05
were considered statistically significant.
Results
There were no differences between the cataract and con-
trol group in demographic data except for a significantly
higher frequency of diabetes in cataract patients com-
pared to the control group (Table 1). Men had signifi-
cantly higher E2 levels compared to postmenopausal
women (p < 0.001); the mean level for men in both the
cataract and control group (i.e. all subjects) was 50.1 ±
16.3 pmol/L compared to 13.8 ± 11.8 pmol/L for post-
menopausal women, thus a considerable difference. E2
levels and SOD activity for the cataract and control
group are shown in Table 2, with men and women pre-
sented separately. A negative correlation between age
and E2 levels was seen in a linear regression analysis
(Fig. 1). The higher E2 levels in men compared to post-
menopausal women are also evident from the figure.
Multivariate analysis showed significant impact of both
age (p = 0.021) and sex (p = <0.001) on E2 levels, but not
with cataract diagnosis. No correlation between SOD ac-
tivity and E2 levels was found, using a multiple linear re-
gression analysis with age, gender and diagnosis as
covariates and the SOD-plate as a fixed factor in the
model (Fig. 2). No predictors showed significant impact
on SOD activity.
Discussion
The main sources of circulating oestrogen are the ovar-
ies and testes in premenopausal non-pregnant women
and men, respectively. Extragonadal production, like in
adipose tissue, is also of physiologic importance as
source of oestrogen in both men and postmenopausal
women. In the ovaries and testes, oestrogens are bio-
synthesized from cholesterol and testosterone respectively
whereas in extragonadal sites oestrogens are derived from
androgenic precursors such as dehydroepiandrosterone
Table 2 Concentrations of oestradiol (E2) in serum and
superoxide dismutase (SOD) activity in erythrocytes in patients
with age-related cataract and controls
Cataract Controls
Men Women Men Women
n = 37 n = 42 n = 6 n = 16
Oestradiol levels (pmol/L) a 50.7 ± 17.2 15.4 ± 13.0 46.0 ± 9.0 9.6 ± 6.6
n = 41 n = 60 n = 6 n = 16
SOD activity (U/ml) 4.1 ± 0.9 4.1 ± 1.0 3.9 ± 1.2 4.2 ± 1.0
Data presented as mean ± SD
a Oestradiol (17β-oestradiol) levels measured in serum are only presented for
postmenopausal women
Fig. 1 A negative correlation between age and serum oestradiol
(E2) levels was seen in cataract patients and controls with linear
regression analysis. Higher levels of serum E2 levels were evident in
men compared to postmenopausal women
Škiljić et al. BMC Ophthalmology  (2016) 16:210 Page 3 of 5
(DHEA), androstenediol and androstenedione, which can
be converted into testosterone. Oestradiol (E2) is then
biosynthesized through aromatization of testosterone and
subsequently bound to sex hormone-binding globulin
(SHBG) or albumin. Only a small fraction of E2 circulates
free and unbound in the blood. E2 is the predominant
oestrogen during the reproductive years in women and a
dramatic decrease in E2 levels is seen in women entering
menopause [12].
We observed significantly higher E2 levels in men
compared to postmenopausal women. It has previously
been reported that serum E2 levels can be higher in
older men than in older women due to higher levels of
testosterone and DHEA in men, resulting in higher E2
through peripheral aromatization [13, 14]. The reduction
of E2 in women in menopause is thus not only dramatic,
it even drops below the E2 concentration in men, some-
thing that may explain the increased prevalence of cata-
ract in women. This hypothesis is further supported by
studies on HRT and risk of cataract in women, showing
protective effects of exogenously added oestradiol in
postmenopausal women [4–6]. In addition, a large epi-
demiological study on prostate-cancer patients demon-
strated higher incidence of cataract in those treated with
androgen deprivation therapy, which lowers testosterone
levels and consequently also decreases the production of
E2 [15]. Oestradiol has been identified in the aqueous
humour of humans, but the investigators did not find
any differences between cataract patients and controls
nor between men and women, when measuring E2 levels in
aqueous humour [16]. Regarding the potential protective
effects of oestradiol on cataract formation, a possible
upregulation of SOD has been suggested in in vitro
experiments and in animal models [7, 8]. The present
study is the first to actually investigate a possible
correlation between oestradiol concentration and SOD
activity in humans. However, in this study no such
correlation could be found in cataract patients or in
controls. Alternative explanations for the protective
role of oestradiol may be scavenging of reactive oxygen
spices or upregulation of other antioxidant systems.
There have been reports of increased SOD activity in
erythrocytes in cataract patients compared to controls
and the POLA study group showed an increased incidence
of cortical cataract in patients with high SOD activity in
erythrocytes [17–19]. Rajkumar et al. demonstrated in-
creased SOD activity in lens capsule samples from cortical
cataract patients and the activity declined gradually with
age in all samples; the highest levels of SOD were found in
samples from patients 50 years of age or younger [20].
However, conflicting data on SOD activity levels also exist
and there are studies showing decreased SOD activity
levels in erythrocytes, sera and lenses from cataract pa-
tients compared to controls [21–23]. The study size and
size of the control group are limitations in our study and
no difference in SOD activity was seen between cataract
and controls, but few subjects in the control group ren-
ders this comparison difficult.
Conclusion
In conclusion, these findings are in accordance with pre-
vious reports showing higher E2 concentration in men
than in postmenopausal women. Although the present
data does not provide hard proofs that oestradiol pro-
tects against cataract, the results are still supportive for
the hypothesis that it is the decline in oestrogen for
women in menopause that may be cataractogenic. How-
ever, the results do not support that a possible beneficial
effect of oestrogen acts through an E2-mediated upregu-
lation of SOD.
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